# Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease

> **NCT04213391** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 160 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** sulforaphane
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04213391
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-10
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04213391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04213391, "Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04213391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*